Vivimed Labs Ltd · Valuation · TradingHolo

Vivimed Labs Ltd · Valuation · TradingHolo

Multiples

Shown only where the company is comparable with its peers

Multiple	Now	Sector median	Where it sits
P/E	−0.3×	27.5×
Price / Book	−0.2×	3.0×
Price / Sales	0.7×	3.0×
Price / Free cash flow	7.6×	−0.9×
EV / EBITDA	−3.1×	16.7×
Earnings yield	−341.6%	2.4%
Free cash flow yield	13.1%	0.0%	—

P/E at each quarterly report

Price at the report date ÷ trailing twelve-month earnings

No comparable valuation history is available.

Peers

Same market and sector · market cap in USD

Company	Price	Change	Mkt cap (USD)	P/E	ROE	1Y
NSE:SUNPHARMASun Pharmaceuticals Industries Ltd · 🇮🇳 NSE	₹1,748.00	−0.57%	$43.87B	36.5×	13.7%	+4.2%
NSE:DIVISLABDivi's Laboratories Ltd · 🇮🇳 NSE	₹8,950.00	−2.31%	$25B	94.6×	15.3%	+42.3%
NSE:TORNTPHARMTorrent Pharmaceuticals Ltd · 🇮🇳 NSE	₹4,524.40	−1.97%	$17.79B	79.6×	25.8%	+29.0%
NSE:ZYDUSLIFEZydus Lifesciences Ltd · 🇮🇳 NSE	₹1,129.40	−0.49%	$11.69B	22.1×	18.6%	+13.4%
NSE:APOLLOHOSPApollo Hospitals Enterprise Ltd · 🇮🇳 NSE	₹7,730.00	+1.65%	$11.71B	56.3×	20.5%	−3.5%
NSE:LAURUSLABSLaurus Labs Ltd · 🇮🇳 NSE	₹1,970.00	−1.62%	$11.27B	122.3×	16.8%	+113.0%
NSE:CIPLACipla Ltd · 🇮🇳 NSE	₹1,338.00	+0.53%	$11.24B	27.4×	11.3%	−15.1%
NSE:DRREDDYDr Reddy's Laboratories Ltd · 🇮🇳 NSE	₹1,229.50	−0.77%	$10.8B	24.1×	11.4%	−3.5%
NSE:MANKINDMankind Pharma Ltd · 🇮🇳 NSE	₹2,212.60	−2.77%	$9.65B	49.3×	11.7%	−6.4%
NSE:AUROPHARMAAurobindo Pharma Ltd · 🇮🇳 NSE	₹1,571.70	−2.43%	$9.32B	25.9×	9.2%	+48.5%